Neuropace, Inc.
NPCE • NASDAQ
Neuropace, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joel D. Becker, with a market cap of $493.2M.
Market Cap$493.2M
Employees181.0
CEOJoel D. Becker
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Neuropace, Inc. FAQ
Common questions about Neuropace, Inc.
Neuropace, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $21.6M.
Neuropace, Inc. has approximately 181 employees.